Image Of Alendronate Sodium Chemical Structure (Alendronate Sodium Tablets 1)
Alendronate Sodium Tablet
Product Images NDC 0115-1678
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Alendronate Sodium (NDC 0115-1678). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
5mg-30tabs (Alendronate Sodium Tablets 10)
This is a product description of Alendronate Sodium tablets USP with a strength of 5mg. It is recommended for pharmacists to dispense with a medication guide to patients. The tablets should be stored at room temperature and away from children. The manufacturer of this product is Pliva Hrvatska, located in Croatia, and it was distributed by Impax Generics in Hayward, California. The product is a prescription drug and dosage should be determined based on the package insert.*
10mg-30tabs (Alendronate Sodium Tablets 11)
This text describes a medication called Alendronate in 10 mg tablets. The pharmacist is instructed to dispense the sodium, and the usual dosage should be determined by referring to the prescribing information in the package insert. The medication should be stored in a child-resistant, light-resistant container at controlled room temperature. The manufacturer is PLIVA HRVATSKA d.o.0., and the medication is distributed by Impax Generics. There is also a warning to keep the medication out of the reach of children.*
35mg-4tabs (Alendronate Sodium Tablets 12)
The text appears to be a mix of various content, including some numbers, random letters and symbols. However, there is information about a medication called "Alendronate Sodium Tablets USP" with a dosage of "35 mg" and instructions to take "ONE 35 mg TABLET ONCE WEEKLY". The text also advises dispensing the enclosed Medication Guide to each patient. There is also information on how to store the medication. The last line mentions "4TABLETS," which may refer to the quantity of tablets inside the package.*
40mg-30tabs (Alendronate Sodium Tablets 13)
This is a description of a medication called Alendronate, a tablet used for treating various bone conditions. Each tablet contains 52.21mg of alendronate sodium trihydrate (40 mg free acid equivalent). The tablets are for 30 days usage with a usual dosage mentioned in the package insert present along with the medication. Pharmacists are also instructed to dispense the accompanying Medication Guide to each patient. The medication should be stored in a tight, light-resistant container at a controlled room temperature defined in USP. This medication is only available by prescription and is manufactured in Croatia by Pliva Hrvatska d.0.0 and distributed by Impax Generics in Hayward, CA.*
70mg-4tabs (Alendronate Sodium Tablets 14)
This is a description of a medication called alendronate sodium tablets USP with a weekly dosage of one 70mg tablet. The package contains four tablets, each containing 91.57mg of alendronate sodium hydride. It's important to read the enclosed medication guide before taking the medication, store it at room temperature and keep it out of reach of children. The text contains a prescription number and manufacturing details, but no further details about the medication's purpose or benefits.*
Figure 1 (Alendronate Sodium Tablets 2)
Figure 2 (Alendronate Sodium Tablets 3)
Figure 3a (Alendronate Sodium Tablets 4)
This appears to be a graph or chart with the title "S. Study" and some information about a medication called "plendronate" in the dosage of 10mg as a free acid. There is also a reference to "Flaceho" and a time scale in months. Without additional context or visual information, it is not possible to provide a more detailed or accurate description.*
Figure 3b (Alendronate Sodium Tablets 5)
This is a not-available description as the given text does not provide any useful information to generate a description.*
Figure 4a (Alendronate Sodium Tablets 6)
Figure 4b (Alendronate Sodium Tablets 7)
Figure 5 (Alendronate Sodium Tablets 8)
Figure 6 (Alendronate Sodium Tablets 9)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
